Inventor · disambiguated record
Emi Hosaka
Also filed as: HOSAKA EMI
39 granted patents·9 pending applications·1,725 citations·filing 2001–2019
98Inventor score
Top patents by PatentIndex Score
48 records- 0199US7214775B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KOGYO KK·Filed 2005·Granted May 8, 2007·363 cites·7 claims
- 0298US7737325B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 15, 2010·55 cites·14 claims
- 0398US7708992B2Methods for producing antibody compositions with increased ADCCKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted May 4, 2010·51 cites·16 claims
- 0498US7651688B2Method of modulating the activity of functional immune molecules to CD52KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Jan 26, 2010·47 cites·3 claims
- 0598US7425446B2Antibody composition-producing cellKYOWA HAKKO KOGYO KK·Filed 2005·Granted Sep 16, 2008·93 cites·6 claims
- 0698US7393683B2Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferaseKYOWA HAKKO KOGYO KK·Filed 2005·Granted Jul 1, 2008·63 cites·6 claims
- 0798US6946292B2Cells producing antibody compositions with increased antibody dependent cytotoxic activityKYOWA HAKKO KOGYO KK·Filed 2001·Granted Sep 20, 2005·566 cites·12 claims
- 0897US8067232B2Antibody composition-producing cell with inactivated A-1,6-fusocyltransferaseKANDA YUTAKA·Filed 2008·Granted Nov 29, 2011·45 cites·5 claims
- 0997US7846725B2Antibody composition-producing cell in which enzyme expression is inhibited by RNAiKYOWA HAKKO KIRIN CO LTD·Filed 2008·Granted Dec 7, 2010·35 cites·6 claims
- 1097US7741442B2Antibody composition exhibiting increased cellular cytotoxicity due to glycosylationKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 22, 2010·32 cites·4 claims
- 1197US7718175B2Method of modulating the activity of functional immune molecules to interleukin-5 receptor proteinKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted May 18, 2010·32 cites·3 claims
- 1297US7687061B2Method of modulating the activity of functional immune molecules to Her-2KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 30, 2010·29 cites·3 claims
- 1397US7682610B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 23, 2010·33 cites·3 claims
- 1496US7763246B2Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptorKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Jul 27, 2010·23 cites·3 claims
- 1596US7708997B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted May 4, 2010·24 cites·3 claims
- 1696US7682611B2Method of modulating the activity of functional immune molecules to CXCR4 proteinKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 23, 2010·26 cites·3 claims
- 1796US7655228B2Method of modulating the activity of functional immune molecules to GM2KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Feb 2, 2010·24 cites·3 claims
- 1893US7842797B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Nov 30, 2010·14 cites·6 claims
- 1992US8039595B2Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylationKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Oct 18, 2011·9 cites·5 claims
- 2092US7504104B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KOGYO KK·Filed 2002·Granted Mar 17, 2009·28 cites·19 claims
- 2190US8679491B2Method of modulating the activity of functional immune moleculesHANAI NOBUO·Filed 2009·Granted Mar 25, 2014·12 cites·2 claims
- 2290US7064191B2Process for purifying antibodyKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jun 20, 2006·89 cites·8 claims
- 2389US8101185B2Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylationKANDA YUTAKA·Filed 2010·Granted Jan 24, 2012·6 cites·4 claims
- 2487US8895266B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2012·Granted Nov 25, 2014·4 cites·4 claims
- 2587US8158760B2Glycoengineered, recombinant antibodyKANDA YUTAKA·Filed 2009·Granted Apr 17, 2012·4 cites·4 claims
- 2686US8329443B2Antibody composition-producing cellKANDA YUTAKA·Filed 2011·Granted Dec 11, 2012·4 cites·4 claims
- 2786US8110195B2Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibodyKANDA YUTAKA·Filed 2010·Granted Feb 7, 2012·4 cites·4 claims
- 2883US10233247B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Mar 19, 2019·2 cites·6 claims
- 2974US8143058B2Human CDR-grafted antibody and antibody fragment thereofSHITARA KENYA·Filed 2010·Granted Mar 27, 2012·1 cites·5 claims
- 3074US2019360015A1Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2019·Application pending·0 cites
- 3174US2010143388A1Antibody Composition-Producing CellKYOWA HAKKO KIRIN CO LTD·Filed 2009·Application pending·0 cites
- 3274US2020017593A1Method of producing antibodies with n-glycoside-linked sugar chains lacking fucosylationKYOWA HAKKO KIRIN CO LTD·Filed 2019·Application pending·0 cites
- 3373US8367407B2Cells with altered fucosylation and producing antibodies therefromKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Feb 5, 2013·0 cites·14 claims
- 3473US7404953B2Methods using eosinophil-specific apoptosis inducerKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jul 29, 2008·6 cites·12 claims
- 3572US9409982B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Aug 9, 2016·0 cites·7 claims
- 3668US10590203B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KIRIN CO LTD·Filed 2017·Granted Mar 17, 2020·0 cites·5 claims
- 3768US10233475B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2016·Granted Mar 19, 2019·0 cites·20 claims
- 3868US9051371B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Jun 9, 2015·0 cites·4 claims
- 3967US2017240647A1Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2017·Application pending·0 cites
- 4066US8900584B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KIRIN CO LTD·Filed 2013·Granted Dec 2, 2014·0 cites·6 claims
- 4166US8093361B2Anti-perp antibodyOCHIAI ATSUSHI·Filed 2005·Granted Jan 10, 2012·1 cites·33 claims
- 4264US2007010009A1Antibody Composition-Producing CellKYOWA HAKKO KOGYO KK·Filed 2006·Application pending·0 cites
- 4363US2006064781A1Antibody composition-producing cellKYOWA HAKKO KOGYO KK·Filed 2005·Application pending·0 cites
- 4461US10131711B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KIRIN CO LTD·Filed 2015·Granted Nov 20, 2018·0 cites·10 claims
- 4561US2011027271A1Antibody composition exhibiting cellular cytotoxicty due to glycosylationKYOWA HAKKO KIRIN CO LTD·Filed 2010·Application pending·0 cites
- 4660US2012177643A1Human cdr-grafted antibody and antibody fragment thereofSHITARA KENYA·Filed 2012·Application pending·0 cites
- 4746US2008241884A1Fused Protein CompositionSHITARA KENYA·Filed 2004·Application pending·0 cites
- 4844US8093362B2Anti-PERP recombinant antibodyOCHIAI ATSUSHI·Filed 2006·Granted Jan 10, 2012·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Emi Hosaka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →